NewsRx

Search our medical news database

Surgical Technology

U.S. FDA issues approvable letter for ceramic-on-ceramic hip system

Published in Medical Letter on the CDC and FDA, October 16th, 2005

Biomet, Inc., (BMET) announced that the U.S. Food & Drug Administration (FDA) has issued an approvable letter for Biomet's C2a-Taper Acetabular System.

Product rollout in the United States will commence immediately following the receipt of a final approval order, which Biomet projects will be issued by the end of calendar 2005.

"The introduction of the C2a-Taper Acetabular System will further enhance Biomet's hip articulation portfolio and offer surgeons who prefer ceramic-on-ceramic technology a compelling design," noted Biomet President and CEO Dane A. Miller, PhD. "The C2a-Taper Acetabular System features Biomet's Porous Plasma Spray (PPS)...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook